Infant ibuprofen recall expanded

Tris Pharma, Inc Expands Its Voluntary Nationwide Retail Recall of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, Due to Higher Concentration of Ibuprofen.

"No adverse events have been reported to Tris Pharma Inc., but ibuprofen concentrations have been found as high as 10% above the specified limit, according to the company. The higher potency could cause nausea, vomiting, diarrhea, tinnitus, headache and gastrointestinal bleeding, according to the company. Infants may be more vulnerable to permanent kidney damage."

-American Academy of Pediatrics

Please use the following links to learn more:

FDA- Images and Details https://www.fda.gov/Safety/Recalls/ucm630112.htm

AAP- Announcement http://www.aappublications.org/news/2019/01/31/ibuprofenrecall013119


Featured Posts
Recent Posts
Follow Us
  • Facebook Classic

2020 Cattlemen Road Suite 600,Sarasota, Fl. 34232.

2447 Sycamore Street, North Port, Fl. 34289

© 2021 by Comprehensive Childcare Associates

P: 941-955-5191

F:941-366-7582